MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Autonomic dysfunction"

  • 2016 International Congress

    Loss of heart rate variability in ALS: Time and frequency domain assessment

    P. Congiu, G. Milioli, G. Borghero, G. Gioi, F. Marrosu, M. Puligheddu, A.L. Goldberger, S. Mariani (Monserratoo, Italy)

    Objective: The aim of this study was to investigate alterations in cardiac autonomic control during sleep in patients affected by ALS. Background: Amyotrophic lateral sclerosis…
  • 2016 International Congress

    Irritable bowel syndrome is more prevalent than functional constipation in Parkinson’s disease: Clinical spectrum and changes in gut microbiota

    T. Mertsalmi, V. Aho, P.A.B. Pereira, L. Paulin, E. Pekkonen, P. Auvinen, F. Scheperjans (Helsinki, Finland)

    Objective: To assess distal functional gastrointestinal (GI) symptoms and their connection to fecal microbiota (FM) in Parkinson (PD) patients. Background: The majority of PD patients…
  • 2016 International Congress

    Use of nicotine gum to treat acute low blood pressure in Parkinson’s disease

    J. DiFrancisco-Donoghue, A. Leder, M.K. Jung, W.G. Werner (Old Westbury, NY, USA)

    Objective: To evaluate (1) how nicotine chewing gum is tolerated (2) how nicotine chewing gum affects acute low blood pressure (BP) in Parkinson's disease (PD).…
  • 2016 International Congress

    Application of Parkinson’s well-being map to assess impairment of digestive system in patients of Tomsk region, Russia

    Y. Mironova, I. Zhukova, N. Zhukova, V. Alifirova, O. Izhboldina, A. Latypova, M. Nikitina (Tomsk, Russia)

    Objective: The aim of this study was to evaluate results of using Parkinson's Well-Being Map (WBM) in assessment of digestive and gut dysfunction in patients…
  • 2016 International Congress

    Effects of pyridostigmine bromide vs. fludrocortison in the treatment of orthostatic hypotension in Parkinson’s disease

    S.R. Schreglmann, F. Büchele, M. Sommerauer, L. Epprecht, G. Kägi, S. Hägele-Link, O. Götze, L. Zimmerli, D. Waldvogel, C.R. Baumann (London, United Kingdom)

    Objective: To report results of an investigator-initiated trial to show the non-inferiority of pyridostigmine bromide (PB) vs. fludrocortisone (FC) in the treatment of symptomatic orthostatic…
  • 2016 International Congress

    Parkinson’s disease prodromal dysautonomia versus pure autonomic failure and MSA

    M. Rosso, A. Merola, A.J. Espay, S. Maule, M. Zibetti, A. Romagnolo, L. Lopiano (Torino, Italy)

    Objective: To report the long-term follow-up (10 years) of a patient with severe autonomic dysfunction as presenting symptom of Parkinson's disease (PD), analyzing the possible…
  • 2016 International Congress

    Evaluation of droxidopa dosing and clinical response in 50 consecutive patients with Parkinson’s disease and symptomatic neurogenic orthostatic hypotension

    S.H. Isaacson, S. Brillman, N. Chhabria (Boca Raton, FL, USA)

    Objective: To determine the effect of droxidopa on clinical symptoms and standing systolic blood pressure in patients with Parkinson's disease (PD) and neurogenic orthostatic hypotention…
  • 2016 International Congress

    Impact of autonomic dysfunction on disease progression and survival in Parkinson’s disease

    E. De Pablo-Fernandez, C. Tur, T. Revesz, J.L. Holton, T.T. Warner (London, United Kingdom)

    Objective: To determine how autonomic dysfunction influences disease progression and survival in Parkinson's disease (PD). Background: Autonomic dysfunction is a common feature in PD and…
  • 2016 International Congress

    Improvement in posture, pain, and cardiac autonomic function in a prospective study of osteopathic manipulative medicine and physical therapy for camptocormia in Parkinson’s disease

    J.D. Mancini, D.M. Pasternack, N. Caruana, A. Leder (Old Westbury, NY, USA)

    Objective: A prospective cohort study of the effectiveness of osteopathic manipulative medicine (OMM) and physical therapy in improving postural control and dysautonomia in Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley